...
首页> 外文期刊>JAMA: the Journal of the American Medical Association >FDA opioid safety plan promotes patient, physician education to prevent abuse.
【24h】

FDA opioid safety plan promotes patient, physician education to prevent abuse.

机译:FDA阿片类药物安全计划促进患者,医师的教育,以防止滥用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A PROPOSAL FROM THE US FOOD and Drag Administration (FDA) to curb overdoses of long-acting and extended-release opioid medications calls on drug makers to provide voluntary clinician and patient safety education, despite earlier statements from the agency that such steps would provide little improvement over existing safety efforts.In February 2009, the agency first announced it would require the makers of this class of drugs to develop a joint plan to reduce unintentional overdoses involving their products. The announcement was a response to increasing rates of overdose and abuse of opioid pain medications. Data from the Substance Abuse and Mental Health Services Administration's Drug Abuse Warning Network (DAWN) show that emergency department visits involving nonmedical use of prescription opi-oids increased 111% between 2004 and 2008, with the estimated number of visits rising from 144 644 to 305 885 per year (MMWR Morb Mortal Wkly Rep. 2010;59[23]:705-709).
机译:美国食品和药物管理局(FDA)的一项遏制长效和缓释阿片类药物用药过量的提案呼吁药物生产商提供自愿的临床医生和患者安全教育,尽管该机构此前曾表示此类步骤将提供很少的帮助改进现有安全措施。2009年2月,FDA首次要求此类药物的制造商制定一项联合计划,以减少涉及其产品的无意用药过量。该公告是对过量服用阿片类止痛药和滥用率的回应。药物滥用和心理健康服务管理局的药物滥用警告网络(DAWN)的数据显示,在2004年至2008年之间,涉及非医学类处方阿片类药物的急诊就诊次数增加了111%,估计的就诊次数从144 644次增加到305次每年885(MMWR Morb Mortal Wkly Rep。2010; 59 [23]:705-709)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号